Related Experiment Videos
[Myocardial infarction in patients with infectious endocarditis]
1Novosibirsk State Medical Academy, Krasny pr. 52, 630091 Novosibirsk, Russia.
Kardiologiia
|March 19, 2004
Summary
Myocardial infarction (MI) occurred in 9% of patients with infectious endocarditis, worsening prognosis. Diagnosis was aided by serial ECGs and enzyme elevation, despite atypical presentations.
Area of Science:
- Cardiology
- Infectious Diseases
- Pathophysiology
Background:
- Active infectious endocarditis presents a significant risk for developing myocardial infarction (MI).
- MI in this context is linked to a more severe clinical course and poorer outcomes for infectious endocarditis patients.
Purpose of the Study:
- To investigate the incidence, clinical presentation, diagnostic challenges, and underlying causes of myocardial infarction in patients with active infectious endocarditis.
- To elucidate the pathogenesis of MI in infectious endocarditis to improve diagnosis and therapy.
Main Methods:
- Retrospective analysis of 230 patients with active infectious endocarditis.
- Clinical data review, including MI presentation, electrocardiography (ECG), cardiac enzyme levels, and echocardiography.
- Assessment of potential etiological factors such as aortic valve vegetation, aortic insufficiency, and hemostatic disturbances.
Main Results:
- Myocardial infarction (MI) developed in 9% of patients.
- MI presented with pain in 43% and was painless in 57%; initial symptoms included arrhythmias, conduction disturbances, and left ventricular failure in 29%.
- Diagnosis was confirmed in all cases through repetitive ECGs and in 81% via enzyme elevation. Key causes included aortic valve vegetation (47%) and aortic insufficiency (62%), alongside hemostatic abnormalities.
Conclusions:
- Myocardial infarction is a critical complication of infectious endocarditis, significantly impacting prognosis.
- Diagnosis can be challenging due to atypical presentations, necessitating serial ECGs and enzyme monitoring.
- Understanding the multifactorial pathogenesis involving cardiac valve and hemodynamic factors, as well as hemostasis, is crucial for targeted interventions.